| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |